X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
index medicus (26) 26
aged (20) 20
female (19) 19
male (19) 19
middle aged (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
fluorouracil - administration & dosage (9) 9
colorectal neoplasms - drug therapy (8) 8
colorectal neoplasms - pathology (8) 8
oncology (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
camptothecin - analogs & derivatives (7) 7
leucovorin - administration & dosage (7) 7
liver neoplasms - secondary (7) 7
camptothecin - administration & dosage (6) 6
cetuximab (6) 6
colorectal cancer (6) 6
liver neoplasms - drug therapy (6) 6
tomography, x-ray computed (6) 6
treatment outcome (6) 6
aged, 80 and over (5) 5
antineoplastic agents - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
colorectal neoplasms - mortality (5) 5
drug combinations (5) 5
organoplatinum compounds - administration & dosage (5) 5
retrospective studies (5) 5
time factors (5) 5
antibodies, monoclonal - therapeutic use (4) 4
antibodies, monoclonal, humanized (4) 4
bevacizumab (4) 4
colorectal neoplasms - surgery (4) 4
fluorouracil (4) 4
fluorouracil - adverse effects (4) 4
low-dose chemotherapy (4) 4
lymphatic metastasis (4) 4
neoplasm staging (4) 4
oxonic acid - administration & dosage (4) 4
prognosis (4) 4
tegafur - administration & dosage (4) 4
5-fluorouracil (3) 3
adult (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - adverse effects (3) 3
camptothecin - therapeutic use (3) 3
chemotherapy (3) 3
colonic neoplasms - pathology (3) 3
colorectal neoplasms - immunology (3) 3
immunotherapy (3) 3
infusions, intra-arterial (3) 3
irinotecan (3) 3
leucovorin - adverse effects (3) 3
lung neoplasms - secondary (3) 3
metastatic colorectal cancer (3) 3
oxonic acid - therapeutic use (3) 3
rectal neoplasms - drug therapy (3) 3
sigmoid neoplasms - pathology (3) 3
sigmoid neoplasms - surgery (3) 3
tegafur - therapeutic use (3) 3
1st-line chemotherapy (2) 2
angiogenesis inhibitors - administration & dosage (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antineoplastic agents, phytogenic - administration & dosage (2) 2
antitumor-activity (2) 2
biochemical modulation (2) 2
cancer (2) 2
carcinoma (2) 2
chemotherapy, adjuvant (2) 2
colonic neoplasms - drug therapy (2) 2
colorectal neoplasms - diagnostic imaging (2) 2
combination chemotherapy (2) 2
computed tomography (2) 2
continuous-infusion (2) 2
cpt-11 (2) 2
ct imaging (2) 2
disease progression (2) 2
disease-free survival (2) 2
health care sciences & services (2) 2
hepatic artery (2) 2
host immunity (2) 2
leucovorin (2) 2
liver neoplasms - mortality (2) 2
lv/5-fu (2) 2
neoplasm invasiveness (2) 2
neoplasm metastasis (2) 2
oxaliplatin (2) 2
phase-iii (2) 2
rectal neoplasms - surgery (2) 2
rectal-cancer (2) 2
risk factors (2) 2
s-1 (2) 2
sigmoid neoplasms - drug therapy (2) 2
survival analysis (2) 2
survival rate (2) 2
activated autologous lymphocytes (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 04/2017, Volume 44, Issue 4, p. 278
Pain is classified as either nociceptive pain, which results from a nociceptor stimulation, or neuropathic pain, which results from a lesion of the neural... 
Cancer Pain - drug therapy | Neoplasms - complications | Cancer Pain - etiology | Humans | Pain Management | Nociceptive Pain - drug therapy | Pain Measurement
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2013, Volume 72, Issue 1, pp. 209 - 215
The imaging factor predicting the response to bevacizumab (BV) as concomitant chemotherapy has yet to be determined. This study examined correlation between... 
Angiogenesis | Chemotherapy | Medicine & Public Health | Computed tomography | Contrast enhancement | Colorectal cancer | Oncology | Cancer Research | Pharmacology/Toxicology | Bevacizumab | ADVANCED HEPATOCELLULAR-CARCINOMA | MULTIDETECTOR ROW CT | INITIAL-EXPERIENCE | MICROVESSEL DENSITY | TUMOR ANGIOGENESIS | PANCREATIC-CARCINOMA | LIVER METASTASES | RECTAL-CANCER | ONCOLOGY | IMAGING FEATURES | PHARMACOLOGY & PHARMACY | ENDOTHELIAL GROWTH-FACTOR | Leucovorin - administration & dosage | Liver - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Drug Resistance, Multiple | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Tomography, X-Ray Computed | Fluorouracil - therapeutic use | Angiogenesis Inhibitors - administration & dosage | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Liver - drug effects | Colorectal Neoplasms - drug therapy | Liver - diagnostic imaging | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Leucovorin - therapeutic use | Liver Neoplasms - pathology | Retrospective Studies | Liver Neoplasms - secondary | Antibodies, Monoclonal, Humanized - therapeutic use | Liver Neoplasms - drug therapy | Liver Neoplasms - diagnostic imaging | Contrast Media | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Antimitotic agents | CT imaging | Metastasis | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Journal of Palliative Medicine, ISSN 1096-6218, 06/2018, Volume 21, Issue 6, pp. 751 - 765
Background: It is important for cancer patients to receive end-of-life care at the desired place. Objective: To identify issues in selection of place for... 
Original Articles | cancer patient | home healthcare | survivorship | end-of-life care | POPULATION | INFORMATION | DEATH | BREAST-CANCER | PREFERENCES | PREDICTORS | HEALTH CARE SCIENCES & SERVICES | SOCIAL SUPPORT | TERMINALLY-ILL PATIENTS | SURVIVORS | CAREGIVERS
Journal Article
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 01/2008, Volume 28, Issue 1B, pp. 373 - 378
Anticancer drugs may frequently induce host immunosuppression and symptomatic toxicities. Once symptomatic toxicity occurs, the patient's quality-of-life (QOL)... 
CD4 | Low-dose chemotherapy | T-cell | Colorectal cancer | Soluble IL-2R | CD25 | Host immunity | colorectal cancer | SOLUBLE INTERLEUKIN-2 RECEPTOR | 1ST-LINE CHEMOTHERAPY | LEUCOVORIN PLUS 5-FLUOROURACIL | CD4(+)CD25(+) T-cell | low-dose chemotherapy | ONCOLOGY | SERUM LEVELS | POLYMORPHISM PREDICTS | soluble IL-2R | REGULATORY T-CELLS | NON-HODGKINS-LYMPHOMA | IL-2 RECEPTOR | host immunity | SELF-TOLERANCE | Leucovorin - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | CD4-CD8 Ratio | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | T-Lymphocytes - drug effects | Colorectal Neoplasms - drug therapy | Leukocytes, Mononuclear - immunology | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Leukocytes, Mononuclear - drug effects | Receptors, Interleukin-2 - biosynthesis | Receptors, Interleukin-2 - blood | Tegafur - adverse effects | Oxonic Acid - administration & dosage | Oxonic Acid - adverse effects | Colorectal Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Tegafur - administration & dosage | T-Lymphocytes - immunology | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Cytokines - biosynthesis | Drug Combinations | Index Medicus
Journal Article
Annals of Cancer Research and Therapy, ISSN 1344-6835, 2009, Volume 17, Issue 1, pp. 25 - 28
We herein report a case of curative resection, after a response to chemotherapy with mFOLFOX6, for sigmoid colon cancer which had been unresectable due to an... 
neoadjuvant chemotherapy | mFOLFOX6 | Colon cancer | Neoadjuvant chemotherapy
Journal Article
Journal Article
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons), ISSN 0385-7883, 2014, Volume 39, Issue 1, pp. 39 - 44
Journal Article
Nippon Daicho Komonbyo Gakkai Zasshi, ISSN 0047-1801, 2014, Volume 67, Issue 7, pp. 460 - 464
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.